Abstract
Chronic stress has detrimental effects on brain structures and functions. Previous studies mainly focused on prefrontal cortex and hippocampus, given their well-described roles in cognition and emotive processing. Chronic stress also leads to changes in other neural circuits, such as the olfactory system. Olfactory deficits were reported in both animal models and patients with depression. The present review summarizes the evidence linking chronic stress to neuropathology in the olfactory system, and analyzes the potential mechanistic insights underlying these changes. We propose also that olfactory system-targeting therapies could be beneficial to certain symptoms of patients suffering from stress-related neurological diseases.
Keywords: Chronic stress, limbic system, neurogenesis, olfaction.
CNS & Neurological Disorders - Drug Targets
Title:Chronic Stress Impacts on Olfactory System
Volume: 14 Issue: 4
Author(s): Ti-Fei Yuan, Gonglin Hou and Oscar Arias-Carrion
Affiliation:
Keywords: Chronic stress, limbic system, neurogenesis, olfaction.
Abstract: Chronic stress has detrimental effects on brain structures and functions. Previous studies mainly focused on prefrontal cortex and hippocampus, given their well-described roles in cognition and emotive processing. Chronic stress also leads to changes in other neural circuits, such as the olfactory system. Olfactory deficits were reported in both animal models and patients with depression. The present review summarizes the evidence linking chronic stress to neuropathology in the olfactory system, and analyzes the potential mechanistic insights underlying these changes. We propose also that olfactory system-targeting therapies could be beneficial to certain symptoms of patients suffering from stress-related neurological diseases.
Export Options
About this article
Cite this article as:
Yuan Ti-Fei, Hou Gonglin and Arias-Carrion Oscar, Chronic Stress Impacts on Olfactory System, CNS & Neurological Disorders - Drug Targets 2015; 14 (4) . https://dx.doi.org/10.2174/1871527314666150429111356
DOI https://dx.doi.org/10.2174/1871527314666150429111356 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Experimental Treatment Options in Absence Epilepsy
Current Pharmaceutical Design Neuroprotection and Hypothermia in Infants and Children
Current Drug Targets Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Nongenomic Thyroxine Regulation of Voltage-gated Sodium Current During Embryonic Development
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) NLRP3 Inflammasome Activation Leads to Epileptic Neuronal Apoptosis
Current Neurovascular Research Current Applications of Artificial Neural Networks in Biochemistry with Emphasis on Cancer Research
Current Biochemical Engineering (Discontinued) Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders
Protein & Peptide Letters P-gp Transporter and its Role in Neurodegenerative Diseases
Current Topics in Medicinal Chemistry A Review on Synthesis of Benzothiazole Derivatives
Current Organocatalysis Activation of Adenosine Receptor Potentiates the Anticonvulsant Effect of Phenytoin Against Amygdala Kindled Seizures
CNS & Neurological Disorders - Drug Targets Protective Effects of the Caffeine Against Neurodegenerative Diseases
Current Medicinal Chemistry Lafora Progressive Myoclonus Epilepsy: Recent Insights into Cell Degeneration
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Trends and Applications of Brain Computer Interfaces
Current Signal Transduction Therapy Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
Current Pharmaceutical Design Anti-NMDA Receptor Encephalitis in Psychiatry
Current Psychiatry Reviews An Integrated Drug Development Approach Applying Topological Descriptors
Current Computer-Aided Drug Design EPO and EPO-Receptor System as Potential Actionable Mechanism for the Protection of Brain and Heart in Refractory Epilepsy and SUDEP
Current Pharmaceutical Design Characterization of Single Nucleotide Polymorphisms of Cytochrome P450 in an Australian Deceased Sample
Current Drug Metabolism Adult Neurogenesis: Can Analysis of Cell Cycle Proteins Move Us “Beyond BrdU”?
Current Pharmaceutical Biotechnology